Skip to main content
. 2019 Mar;7(6):118. doi: 10.21037/atm.2019.01.62

Table 4. AE occurrence for patients using Yunnan Baiyao capsules.

Categories by coding Frequency (cases) Incidence (ITT) (%) Incidence (PP) (%) Proportion (%)
Nasopharyngitis 92 0.89 0.29 11.92
Fever 76 0.84 0.24 9.84
Diarrhea 61 0.79 0.19 7.90
Nausea 52 0.76 0.17 6.74
Dizziness 37 0.71 0.12 4.79
Rash 34 0.70 0.11 4.40
Wound 33 0.70 0.11 4.27
Epigastric discomfort 31 0.69 0.10 4.02
Flatulence 26 0.68 0.08 3.37
Vomiting 26 0.68 0.08 3.37
Cough 22 0.67 0.07 2.85
Epigastric pain 21 0.66 0.07 2.72
Upper respiratory infection 15 0.64 0.05 1.94
Allergic dermatitis 13 0.64 0.04 1.68
Chest discomfort 12 0.63 0.04 1.55
Constipation 12 0.63 0.04 1.55
Headache 12 0.63 0.04 1.55
Itching 12 0.63 0.04 1.55
Abdominal pain 10 0.63 0.03 1.30
Dyspepsia 9 0.62 0.03 1.17
Parulis 9 0.62 0.03 1.17
Oral ulcer 8 0.62 0.03 1.04
Palpitation 7 0.62 0.02 0.91
Urticaria 7 0.62 0.02 0.91
Loss of appetite 6 0.61 0.02 0.78
Abdominal discomfort 5 0.61 0.02 0.65
Drug hypersensitivity 5 0.61 0.02 0.65
Gastroesophageal reflux 5 0.61 0.02 0.65
Uncomfortable 5 0.61 0.02 0.65
Asthenia 4 0.61 0.01 0.52
Gastrointestinal diseases 4 0.61 0.01 0.52
Pain 4 0.61 0.01 0.52
Postoperative hemorrhage 4 0.61 0.01 0.52
Running nose 4 0.61 0.01 0.52
Thermal burn 4 0.61 0.01 0.52
Bleeding 3 0.61 0.01 0.39
Insomnia 3 0.61 0.01 0.39
Joint pain 3 0.61 0.01 0.39
Dry throat 2 0.60 0.01 0.26
Eczema 2 0.60 0.01 0.26
Erythropoiesis 2 0.60 0.01 0.26
Hypoglycemia 2 0.60 0.01 0.26
Phlebitis 2 0.60 0.01 0.26
Shortness of breath 2 0.60 0.01 0.26
Stuffy nose 2 0.60 0.01 0.26
Acne 1 0.60 0.00 0.13
Acute gastroenteritis 1 0.60 0.00 0.13
Allergic rhinitis 1 0.60 0.00 0.13
Amaurosis 1 0.60 0.00 0.13
Amygdalitis 1 0.60 0.00 0.13
Allergic shock 1 0.60 0.00 0.13
Ankle sprains 1 0.60 0.00 0.13
Chronic gastritis 1 0.60 0.00 0.13
Decubitus ulcer 1 0.60 0.00 0.13
Drowsiness 1 0.60 0.00 0.13
Dry mouth 1 0.60 0.00 0.13
Dysphonia 1 0.60 0.00 0.13
Dysuria 1 0.60 0.00 0.13
Epistaxis 1 0.60 0.00 0.13
Erythema 1 0.60 0.00 0.13
Eye hyperaemia 1 0.60 0.00 0.13
Eyelid edema 1 0.60 0.00 0.13
Flush 1 0.60 0.00 0.13
Gastrointestinal disorder 1 0.60 0.00 0.13
Gum swelling 1 0.60 0.00 0.13
Hemoptysis 1 0.60 0.00 0.13
Hemorrhoid bleeding 1 0.60 0.00 0.13
High blood pressure 1 0.60 0.00 0.13
Hypertrophy of tonsil 1 0.60 0.00 0.13
Hyperuricemia 1 0.60 0.00 0.13
Hypoesthesia 1 0.60 0.00 0.13
Internal fixation of fracture 1 0.60 0.00 0.13
Numb lips 1 0.60 0.00 0.13
Melena 1 0.60 0.00 0.13
Menorrhagia 1 0.60 0.00 0.13
Menstruation delay 1 0.60 0.00 0.13
Slow micturition 1 0.60 0.00 0.13
Numbness after administration contact 1 0.60 0.00 0.13
Oliguria 1 0.60 0.00 0.13
Oropharyngeal pain 1 0.60 0.00 0.13
Otitis media 1 0.60 0.00 0.13
Panmetatarsal pain syndrome 1 0.60 0.00 0.13
Peripheral edema 1 0.60 0.00 0.13
Physical pain 1 0.60 0.00 0.13
Postoperative wound infection 1 0.60 0.00 0.13
Purulent sputum 1 0.60 0.00 0.13
Radial fracture 1 0.60 0.00 0.13
Red skin 1 0.60 0.00 0.13
Scapulohumeral periarthritis 1 0.60 0.00 0.13
Petechia 1 0.60 0.00 0.13
Skin and subcutaneous tissue disease 1 0.60 0.00 0.13
Skin disease 1 0.60 0.00 0.13
Sneezing 1 0.60 0.00 0.13
Sore eyes 1 0.60 0.00 0.13
Stomach bleeding 1 0.60 0.00 0.13
Tachycardia 1 0.60 0.00 0.13
Tailbone pain 1 0.60 0.00 0.13
Throat discomfort 1 0.60 0.00 0.13
Throat pain 1 0.60 0.00 0.13
Tinnitus 1 0.60 0.00 0.13
Toothache 1 0.60 0.00 0.13
Unstable blood pressure 1 0.60 0.00 0.13
Urinary retention 1 0.60 0.00 0.13
Urine erythrocyte positive 1 0.60 0.00 0.13
Urogenital hemorrhage 1 0.60 0.00 0.13
Vaginal bleeding 1 0.60 0.00 0.13
Wound infection 1 0.60 0.00 0.13
Total 772 3.04 2.46 100.00

AE, adverse event; PP, per-protocol; ITT, intention-to-treat.